Particle Therapy Technology for Safe Treatment
Particle Therapy Technology for Safe Treatment

Author: Jay Flanz

Publisher: CRC Press

Published: 2022-01-18

Total Pages: 492

ISBN-13: 1000528065

DOWNLOAD EBOOK

The path from clinical requirements to technical implementation is filtered by the translation of the modality to the technology. An important part of that filter is that the modality be safe. For that to be the case, it is imperative to understand what clinical parameters affect the safety of a treatment and then determine how the technology can affect those parameters. This book provides a practical introduction to particle therapy. It provides a thorough introduction to the technological tools and their applications and then details the components that are needed to implement them. It explains the foundations of beam production and beam delivery that serve to meet the necessary clinical requirements. It emphasizes the relationship between requirements and implementation, including how safety and quality are considered and implemented in the solution. The reader will learn to better understand what parameters are important to achieve these goals. Particle Therapy Technology for Safe Treatment will be a useful resource for professionals in the field of particle therapy in addition to biomedical engineers and practitioners in the field of beam physics. It can also be used as a textbook for graduate medical physics and beam physics courses. Key Features Presents a practical and accessible journey from application requirements to technical solutions Provides a pedagogic treatment of the underlying technology Describes how safety is to be considered in the application of this technology and how safety and quality can be factored into the overall system Author Bio After receiving his PhD in nuclear physics, Dr. Jacob Flanz was the Accelerator Physics Group leader and Principal Research Scientist at the Massachusetts Institute of Technology (MIT), USA, where he designed the recirculator and the GeV stretcher/storage ring. He joined Massachusetts General Hospital (MGH) and Harvard and became project and technical director of proton therapy, with responsibility for specifications, integration, and commissioning ensuring safe clinical performance. He invented the universal nozzle and led the design and implementation of beam scanning at MGH in 2008, including quality assurance. Dr. Flanz has been involved in several FDA applications for particle therapy. He developed and taught the US Particle Accelerator School course "Medical Applications of Accelerators and Beams." He was cochair of education and is currently the president of the Particle Therapy Co-Operative Group. Exercise solutions to accompany this book can be accessed via the 'Instructor Resources' tab on the book webpage.

Low Energy Particle Accelerator-Based Technologies and Their Applications
Low Energy Particle Accelerator-Based Technologies and Their Applications

Author: Vlado Valković

Publisher: CRC Press

Published: 2022-06-22

Total Pages: 391

ISBN-13: 1000599353

DOWNLOAD EBOOK

Low Energy Particle Accelerator-Based Technologies and Their Applications describes types of low energy accelerators, presents some of the main manufacturers, illustrates some of the accelerator laboratories around the globe and shows examples of successful transfers of accelerators to needed laboratories. Key Features: Presents new trends and the state of the art in a field that's growing Provides an overview of numerous applications of such accelerators in medicine, industry, earth sciences, nuclear non-proliferation and oil Fills a gap, with the author drawing on his own experiences with transporting such relatively large machines from one lab to the other that require a tremendous amount of planning, technical and engineering efforts This is an essential reference for advanced students as well as for physicists, engineers and practitioners in accelerator science. About the Author Dr. Vladivoj (Vlado) Valković, a retired professor of physics, is a fellow of the American Physical Society and Institute of Physics (London). He has authored 22 books (from Trace Elements, Taylor & Francis, 1975, to Radioactivity in the Environment, Elsevier, 1st Edition 2001, 2nd Edition 2019), and more than 400 scientific and technical papers in the research areas of nuclear physics, applications of nuclear techniques to trace element analysis in biology, medicine and environmental research. He has lifelong experience in the study of nuclear reactions induced by 14 MeV neutrons. This research has been done through coordination and works on many national and international projects, including US-Croatia bilateral, NATO, IAEA, EU-FP5, FP6 and FP7 projects. Cover photo credit: 3SDH 1 MV Pelletron system with RF source and analysis endstation designed with the intended purpose of aiding in fusion research. It is capable of Ion Beam Analysis (IBA) techniques such as RBS, ERD, PIXE and NRA. Further detectors could be added to the endstation to allow for other techniques. Installed in Japan in 2014. Courtesy of National Electrostatics Corp.

A Special Report on Gene Therapy
A Special Report on Gene Therapy

Author: K. K. Jain

Publisher: John Wiley & Sons

Published: 2000-04-14

Total Pages: 308

ISBN-13: 9780471492900

DOWNLOAD EBOOK

This special report on Gene Therapy Companies by K.K. Jain provides an up-to-date overview of the gene therapy industry. It contains a wealth of very practical information on 105 companies. For each company, information is available on the people to contact, their contact details, a corporate history, the company's technologies and products, financial data, patents held, products in clinical trials, collaborations with other companies and selected publications from the company's scientists. Almost 200 companies were initially considered for inclusion but just over 100 companies were finally selected as they fulfilled the necessary criteria to be classified as a 'Gene Therapy Company,', defined broadly to include cell therapy companies. Not all of the companies devote their activity exclusively to gene therapy but they have sufficient relevance to be included. As part of this project, new companies were discovered that have not been reported in other publications or on the internet. Dr. Jain has spared no effort to ensure that the information is up-to-date and accurate at the time of publishing. In most instances, the information was reviewed by the companies to correct any outdated information or to add any complementary or recent information. In addition to the detailed descriptions of each company, the data is also presented in summary tabular form so that at a glance the reader can identify collaborations within the gene therapy industry, or determine which companies are pursuing strategies involving viral, non-viral or other approaches to gene therapy, and which diseases are being targetted. Given that much of the gene therapy research and development is currently being carried out within the industrial sector, it is important for scientists, managers and investors to have the relevant information at their fingertips. This special report provides that information in one accurate, easy to consult and up-to-date source.

Small Molecules and Peptide-Based Candidates as Therapeutics and Vaccines for COVID-19 Pandemic
Small Molecules and Peptide-Based Candidates as Therapeutics and Vaccines for COVID-19 Pandemic

Author: Da’san Mahmoud Mousa Jaradat

Publisher: Frontiers Media SA

Published: 2021-11-16

Total Pages: 419

ISBN-13: 2889716473

DOWNLOAD EBOOK

Topic Editor Dr. Balakumar Chandrasekaran holds patents relating to N-substituted isatin hydrazones as antimycobacterial and antimicrobial agents, and Pharmaceutical Compounds. Topic Editor Dr. Munir Al-Zeer holds a patent relating to Method for the Preparation of an Influenza Virus. All other Topic Editors declare no competing interests.

The Physics of Multiply and Highly Charged Ions
The Physics of Multiply and Highly Charged Ions

Author: F.J. Currell

Publisher: Springer Science & Business Media

Published: 2013-03-14

Total Pages: 410

ISBN-13: 9401705429

DOWNLOAD EBOOK

It is arguable that most of chemistry and a large portion of atomic physics is concemed with the behaviour of the 92 naturally occurring elements in each of 3 charge states (+1, 0, -1); 276 distinct species. The world of multiply and highly charged ions provides a further 4186 species for us to study. Over 15 times as many! It is the nature of human beings to explore the unknown. This nature is par ticularly strong in physicists although this may not be readily apparent because theses explorations are undertaken in somewhat abstract 'spaces'. It is, then, no surprise that we have begun to explore the realm of multiply and highly charged ions. Over the past few decades, a consistent1y high quality body of work has emerged as the fruits of this exploration. This intemationally based subject, pursued in universities and research laboratories worldwide, has ex panded beyond its roots in atomic physics. We now see it embracing elements of surface science, nuclear physics and plasma physics as well as drawing on a wide range of technologies. This speciality offers new tests of some of our most fundamental ideas in physics and simultaneously new medical cures, new ways of fabricating electronic gadgets, a major hope for clean sustainable energy and explanations for astrophysical phenomena. It is both a deeply fundamental and a widely applicable area of investigation.

Pharmacokinetics
Pharmacokinetics

Author: Leslie Z. Benet

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 537

ISBN-13: 1461327997

DOWNLOAD EBOOK

Neutron Capture Therapy
Neutron Capture Therapy

Author: Wolfgang A.G. Sauerwein

Publisher: Springer Science & Business Media

Published: 2012-11-05

Total Pages: 545

ISBN-13: 3642313345

DOWNLOAD EBOOK

Neutron capture therapy (NCT) is based on the ability of the non-radioactive isotope boron-10 to capture thermal neutrons with very high probability and immediately to release heavy particles with a path length of one cell diameter, which in principle allows for tumor cell-selective high-LET particle radiotherapy. This book provides a comprehensive summary of the progress made in NCT in recent years. Individual sections cover all important aspects, including neutron sources, boron chemistry, drugs for NCT, dosimetry, and radiation biology. The use of NCT in a variety of malignancies and also some non-malignant diseases is extensively discussed. NCT is clearly shown to be a promising modality at the threshold of wider clinical application. All of the chapters are written by experienced specialists in language that will be readily understood by all participating disciplines.